1. Home
  2. ALDX vs DDD Comparison

ALDX vs DDD Comparison

Compare ALDX & DDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • DDD
  • Stock Information
  • Founded
  • ALDX 2004
  • DDD 1986
  • Country
  • ALDX United States
  • DDD United States
  • Employees
  • ALDX N/A
  • DDD N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • DDD Computer peripheral equipment
  • Sector
  • ALDX Health Care
  • DDD Technology
  • Exchange
  • ALDX Nasdaq
  • DDD Nasdaq
  • Market Cap
  • ALDX 313.4M
  • DDD 360.4M
  • IPO Year
  • ALDX 2014
  • DDD N/A
  • Fundamental
  • Price
  • ALDX $5.60
  • DDD $3.16
  • Analyst Decision
  • ALDX Strong Buy
  • DDD Buy
  • Analyst Count
  • ALDX 2
  • DDD 2
  • Target Price
  • ALDX $9.50
  • DDD $5.00
  • AVG Volume (30 Days)
  • ALDX 715.8K
  • DDD 4.5M
  • Earning Date
  • ALDX 11-06-2025
  • DDD 11-25-2025
  • Dividend Yield
  • ALDX N/A
  • DDD N/A
  • EPS Growth
  • ALDX N/A
  • DDD N/A
  • EPS
  • ALDX N/A
  • DDD N/A
  • Revenue
  • ALDX N/A
  • DDD $413,342,000.00
  • Revenue This Year
  • ALDX N/A
  • DDD N/A
  • Revenue Next Year
  • ALDX $36.23
  • DDD $1.78
  • P/E Ratio
  • ALDX N/A
  • DDD N/A
  • Revenue Growth
  • ALDX N/A
  • DDD N/A
  • 52 Week Low
  • ALDX $1.14
  • DDD $1.32
  • 52 Week High
  • ALDX $7.20
  • DDD $5.00
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 59.73
  • DDD 72.25
  • Support Level
  • ALDX $5.13
  • DDD $2.80
  • Resistance Level
  • ALDX $5.78
  • DDD $3.29
  • Average True Range (ATR)
  • ALDX 0.23
  • DDD 0.27
  • MACD
  • ALDX 0.06
  • DDD 0.03
  • Stochastic Oscillator
  • ALDX 84.00
  • DDD 72.29

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

About DDD 3D Systems Corporation

3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.

Share on Social Networks: